Python libraries that replace hundreds of lines of custom code. LiteLLM, Instructor, Tenacity, and 5 more I use in every ...

Open Task Manager on a Windows 11 PC, and it's easy to panic no matter how much RAM you have. Even without many apps open, your computer will likely be using more than 50% of its memory. And while ...

In the high-tech, high-competition AI field, we are seeing new versions of models rolled out by the frontier companies (OpenAI, Google and Anthropic) every month and a half. I included a Release ...

Exponent demonstrates strong demand recovery, with Q2 revenue before reimbursement up 12% to $148.9M and EBITDA margin rising to 28.7%. I see sustainable growth potential, but hiring discipline and ...

“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...

Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...

Ask a roomful of senior executives what AI can do for their business, and the answers will probably cluster around the same themes: lower costs, smaller headcount, faster processes, leaner operations.

Gen Z might be using the abbreviation for “point of view” incorrectly. But linguists think it’s exciting. By Nitsuh Abebe Two months ago, Griffin Bassett uploaded one of the language-education videos ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...